CYP2D6 is a highly polymorphic pharmacogene responsible for the metabolism of more than 20% of commonly prescribed drugs. Clinical implementation of CYP2D6 pharmacogenetics relies on star allele nomenclature and the Activity Score system, yet substantial interindividual variability in drug exposure remains unexplained....
Antonio Asensi-Cantó, Wendy Y. Wang, Erin C. Boone et al.· Pharmacogenetics & Genomics· 0 citations
The NAT2 pharmacogene is essential in drug metabolism, particularly for aromatic amines and hydrazines. Genetic variations in NAT2 categorize individuals as rapid, intermediate, or poor metabolizers based on their acetylation capacity to inform dosing guidelines. Genotyping and short‐read sequencing allele calling meth...
Shobana John, Erin C. Boone, B. Yoo et al.· Clinical pharmacology and th...· 0 citations
It is demonstrated that rs75017182‐ C promotes alternative splicing in the minigene plasmid model, and that the level of splicing may be affected by additional variants in linkage disequilibrium with rs75017182.
L. Hahn, Brianna M. Bembenek, Kelly J. Bouchonville et al.· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.